Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share of Common Stock

v3.20.1
Net Loss Per Share of Common Stock
3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Net Loss Per Share of Common Stock

Note 7 – Net Loss per Share of Common Stock

 

Basic net loss per share is computed by dividing net loss by the weighted average common shares outstanding. Diluted net loss per share is computed by dividing net loss by the weighted average common shares outstanding, which includes potentially dilutive effect of stock options, warrants and senior convertible notes. Since we experienced a loss for both periods presented, including any dilutive common shares outstanding would have an anti-dilutive impact on diluted net loss per share, and as shown below were excluded from the computation. The treasury-stock method is used to determine the dilutive effect of our stock options and warrants grants, and the if-converted method is used to determine the dilutive effect of the Senior Notes.

 

The computation of net loss per share for the three months ended March 31, 2020 and 2019 was as follows:

 

   

Three months ended

March 31,

 
    2020     2019  
Basic and diluted net loss per share:                
Net loss   $ (874,336 )   $ (750,832 )
Weighted average number of common shares-basic and diluted     5,515,447       5,525,009  
                 
Basic and diluted net loss per share   $ (0.16 )   $ (0.14 )

 

We have determined the sale of the 2019 Senior Notes in late 2019, which are convertible into common stock at a conversion rate of $14.28 per share, triggered the full ratchet anti-dilution provision of the common stock we sold in 2018 Private Placement Transactions. As a result, those shareholders were entitled to 28,971 shares of common stock in the fourth quarter of 2019. We will issue 28,971 shares of common stock to these shareholders in 2020. For purposes of computing our basic and diluted EPS, we included these shares in our weighted number of common shares outstanding for the three months ended March 31, 2020.

 

The following potentially dilutive securities were excluded from the computation of diluted net income per share as their effect would have been anti-dilutive for the periods presented.

 

    2020     2019  
Stock options and purchase warrants     725,423       642,657  
Senior convertible notes     57,500       17,854